SecBot SecBot
144 ·Filed Nov 2, 2026

NBIX

NEUROCRINE BIOSCIENCES INC
NEUTRAL
Impact 2/10
Horizondays Processed14d 9h ago SEC0001950047-26-010581
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The sale is pre-planned under a 10b5-1 trading plan, reducing the likelihood of opportunistic insider selling. Monitor for any subsequent Form 4 filings to confirm execution and for any changes in insider selling patterns.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$164.85
T+0 close · Nov 2, 2026 · via day close
Latest settled
+2.60%
T+5 · $169.14 · next T+20 in 15d
Vs SPY
+3.19%
α at T+5
Latest observation
+1.68%
T+8 · FF3 residual α
  1. T+0 · Nov 3 $164.85entry
  2. T+1 · 13d ago +0.73%α −0.92% · $166.05
  3. T+5 · 7d ago +2.60%α +3.19% · $169.14
  4. T+9 · todayOpen
  5. T+20 · in 15d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Director George J. Morrow filed a Form 144 notice of intent to sell 14,700 shares of Neurocrine Biosciences common stock, with an approximate market value of $2.15 million based on the filing date. The shares are to be received upon exercise of stock options, and the sale is planned under a Rule 10b5-1 trading plan adopted on May 26, 2026.

Key Facts

  • Director George J. Morrow filed Form 144 to sell 14,700 shares of Neurocrine Biosciences common stock.
  • The approximate market value of the proposed sale is $2,147,670.
  • Shares will be acquired upon exercise of stock options.
  • The sale is planned under a Rule 10b5-1 trading plan adopted on May 26, 2026.
  • The filing date is November 2, 2026.
  • The proposed sale represents about 0.014% of Neurocrine's $14.9B market cap.
  • A prior sale of 300 shares on October 30, 2026 is also noted in the filing.

Financial Impact

Proposed sale of 14,700 shares valued at approximately $2.15 million, representing a small fraction of the company's $14.9B market cap.

dilution

Risk Factors

  • Form 144 is an intent to sell; the actual sale may not occur.
  • Insider selling, even under a 10b5-1 plan, can be perceived negatively by the market if the volume is large relative to average trading.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
86% bullish (37 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-010581
Document: 0001950047-26-010581-index.html0001950047-26-010581
Document: 0001950047-26-010581.txt0001950047-26-010581

Track record

30 reports on NBIX

Performance horizon

3 of 4 bullish or bearish reports moved the stock their way by T+20. Best: +27.40% at T+60 after the Apr 6, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 10, 20266d ago 144 Neutral 2/10 Entry $174.41 Now $165.31 −5.22% settles Dec 10
  2. Nov 10, 20267d ago PTAB Trial Neutral 3/10 Entry $169.14 Now $165.31 −2.26% settles Dec 9
  3. Nov 10, 20267d ago PTAB Trial Neutral 3/10 Entry $169.14 Now $165.31 −2.26% settles Dec 9
  4. Nov 10, 20267d ago PTAB Trial Neutral 3/10 Entry $169.14 Now $165.31 −2.26% settles Dec 9
  5. Nov 2, 202614d ago Press Release Bullish 6/10 No price data
  6. Nov 2, 202614d ago 144 Neutral 2/10 Viewing Entry $164.85 Now $165.31 +0.28% settles Dec 2
  7. Nov 2, 202614d ago 8-K Bullish 6/10 Entry $164.85 Now $165.31 +0.28% settles Dec 2
  8. Oct 30, 202617d ago 144 Neutral 1/10 Entry $145.35 Now $165.31 +13.73% settles Dec 1
  9. Oct 30, 202617d ago SC 13G Neutral 3/10 Entry $146.10 Now $165.31 +13.15% settles Nov 30
  10. Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $145.53 Now $165.31 +13.59% settles Nov 25
Showing 10 of 30

US Market Status

Market Closed · Opens in 7h 14m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 2, 2026